Pliant Therapeutics Inc (PLRX)
12.76
+0.16
(+1.27%)
USD |
NASDAQ |
Apr 23, 13:06
Pliant Therapeutics Cash and Short Term Investments (Quarterly): 494.24M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 494.24M |
| September 30, 2023 | 523.61M |
| June 30, 2023 | 555.16M |
| March 31, 2023 | 577.31M |
| December 31, 2022 | 331.19M |
| September 30, 2022 | 360.24M |
| June 30, 2022 | 163.60M |
| March 31, 2022 | 178.28M |
| December 31, 2021 | 200.60M |
| Date | Value |
|---|---|
| September 30, 2021 | 221.04M |
| June 30, 2021 | 243.98M |
| March 31, 2021 | 264.10M |
| December 31, 2020 | 276.89M |
| September 30, 2020 | 294.00M |
| June 30, 2020 | 312.47M |
| March 31, 2020 | 141.43M |
| December 31, 2019 | 102.77M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
102.77M
Minimum
Dec 2019
577.31M
Maximum
Mar 2023
308.29M
Average
276.89M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Masimo Corp | 163.00M |
| Liquidia Corp | 83.68M |
| Vor Biopharma Inc | 137.18M |
| CEL-SCI Corp | 3.241M |
| AIM ImmunoTech Inc | 13.07M |